Northeast Pharmaceutical receives subscribed capital
Northeast Pharmaceutical Group Co., Ltd. (Northeast Pharmaceutical) announced on 9 May that it had received a capital of USD133.59 million (RMB850.58 million) from the subscribers, including Liaoning Fangda Group Industrial Co., Ltd. and Shenyang She...
Sorbitol China News 201805